Guardion Health Sciences, Inc. (GHSI): Price and Financial Metrics


Guardion Health Sciences, Inc. (GHSI)

Today's Latest Price: $0.80 USD

0.01 (-0.85%)

Updated Jan 22 4:00pm

Add GHSI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 62 in Consumer Goods

See all "A" rated Strong Buy stocks

GHSI Stock Summary

  • Guardion Health Sciences Inc's stock had its IPO on April 5, 2019, making it an older stock than merely 3.39% of US equities in our set.
  • With a price/sales ratio of 37.06, Guardion Health Sciences Inc has a higher such ratio than 93.13% of stocks in our set.
  • As for revenue growth, note that GHSI's revenue has grown 114.52% over the past 12 months; that beats the revenue growth of 95.19% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Guardion Health Sciences Inc, a group of peers worth examining would be SVVC, ITIC, MSB, CO, and MSN.
  • GHSI's SEC filings can be seen here. And to visit Guardion Health Sciences Inc's official web site, go to www.guardionhealth.com.

GHSI Stock Price Chart Interactive Chart >

Price chart for GHSI

GHSI Price/Volume Stats

Current price $0.80 52-week high $1.04
Prev. close $0.81 52-week low $0.17
Day low $0.76 Volume 15,959,900
Day high $0.83 Avg. volume 50,773,000
50-day MA $0.38 Dividend yield N/A
200-day MA $0.37 Market Cap 73.48M

Guardion Health Sciences, Inc. (GHSI) Company Bio


Guardion Health Sciences, Inc. provides health care services. It offers, Lumega-Z a medical food formulated to replenish and restore the macular protective pigment. The firm also develops medical devices that measures macular pigment density. The company was founded by Michael Favish in 2009 and is headquartered in San Diego, CA.


GHSI Latest News Stream


Event/Time News Detail
Loading, please wait...

GHSI Latest Social Stream


Loading social stream, please wait...

View Full GHSI Social Stream

Latest GHSI News From Around the Web

Below are the latest news stories about Guardion Health Sciences Inc that investors may wish to consider to help them evaluate GHSI as an investment opportunity.

Should Guardion Health Sciences (NASDAQ:GHSI) Be Disappointed With Their 94% Profit?

If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...

Yahoo | January 7, 2021

Guardion Health names industry veteran Bret Scholtes as new president and CEO

Guardion Health Sciences (GHSI) appoints Bret Scholtes as the company's permanent president and CEO, effective Jan. 6, 2021.Scholtes is a veteran of the nutritional products industry having spent the last 9 years as CEO of Omega Protein, a global nutritional products company which traded on NYSE until it was sold to a strategic buyer in late...

Seeking Alpha | December 28, 2020

Guardion Health Sciences Appoints Seasoned Nutritional Products Industry Leader Bret Scholtes as President and Chief Executive Officer

SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition, medical foods and medical devices, with a focus in the ocular health marketplace, today announces the appointment of Bret Scholtes, a veteran of the nutritional products industry for nearly a decade, as its President and Chief Executive Officer, and as a member of the Board of Directors, commencing January 6, 2021. “We are delighted to welcome Bret to Guardion Health Sciences. We believe that his proven business acumen and extensive experience in the nutritional products industry will serve to usher Guardion into a new era of growth and success,” commented Robert Weingarten, Chairman o...

Yahoo | December 28, 2020

Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-V

SAN DIEGO, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition, medical foods and medical devices, with a focus in the ocular health marketplace, announced progress on the introduction of its new vision support/energy drink, Epiq-V, which is under development for the United States and international markets. Epiq-V contains Lutein, a primary ingredient in the Company’s flagship product, Lumega-Z, and is being developed for an adult market as a vision health and support product concurrently with a second formulation for introduction as a visual attention and energy drink primarily focused on the youth market to support video gaming and other close-up...

Yahoo | December 16, 2020

Guardion Health Sciences Announces Newly-Published Data Demonstrating Superior Visual Function and Macular Carotenoid Changes Using Guardion’s Proprietary Lumega-Z® Formulation Compared to AREDS-2 Formulation

New Study Published on October 26, 2020 in Peer-Reviewed Journal “Nutrients”SAN DIEGO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported nutrition, medical foods and medical devices, with a focus in the ocular health marketplace, announced the publication of new data in the journal Nutrients. The study compared the efficacy of Lumega-Z®, the Company’s flagship proprietary nutritional product marketed under the Company’s NutriGuard brand, to the current standard of care, the AREDS-2 soft gel supplement (marketed under the PreserVision® brand by Bausch and Lomb), as measured by changes in vision following a six-month regimen. The study, titled “Visual functi...

Yahoo | October 28, 2020

Read More 'GHSI' Stories Here

GHSI Price Returns

1-mo 133.85%
3-mo 305.68%
6-mo 86.87%
1-year 151.10%
3-year N/A
5-year N/A
YTD 92.77%
2020 88.38%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6211 seconds.